{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:49:56Z","timestamp":1792709396508,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.drudis.2021.12.016","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T04:01:44Z","timestamp":1640232104000},"page":"1218-1235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Experimental murine models of brainstem gliomas"],"prefix":"10.1016","volume":"27","author":[{"given":"Shuting","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2021.12.016_b0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol."},{"issue":"Pt 12","key":"10.1016\/j.drudis.2021.12.016_b0010","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1093\/brain\/124.12.2528","article-title":"Brainstem gliomas in adults: prognostic factors and classification","volume":"124","author":"Guillamo","year":"2001","journal-title":"Brain."},{"issue":"suppl_4","key":"10.1016\/j.drudis.2021.12.016_b0015","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11060-011-0796-x","article-title":"An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing","volume":"108","author":"Aoki","year":"2012","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/neuonc\/nou330","article-title":"Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma","volume":"17","author":"Truffaux","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0030","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"Paugh","year":"2011","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1750-3639.2010.00468.x","article-title":"Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model","volume":"21","author":"Caretti","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.drudis.2021.12.016_b0040","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/neuonc\/nor076","article-title":"Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging","volume":"13","author":"Hipp","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drudis.2021.12.016_b0050","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1158\/1078-0432.CCR-18-0924","article-title":"MELK inhibition in diffuse intrinsic pontine glioma","volume":"24","author":"Meel","year":"2018","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.drudis.2021.12.016_b0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet."},{"key":"10.1016\/j.drudis.2021.12.016_b0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/14737175.2020.1775584","article-title":"Improving long-term survival in diffuse intrinsic pontine glioma","volume":"20","author":"Felker","year":"2020","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.drudis.2021.12.016_b0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"Wu","year":"2014","journal-title":"Nat Genet."},{"key":"10.1016\/j.drudis.2021.12.016_b0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40478-014-0134-6","article-title":"Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma","volume":"2","author":"Misuraca","year":"2014","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.drudis.2021.12.016_b0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3171\/2008.11.PEDS08281","article-title":"Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies","volume":"3","author":"Frazier","year":"2009","journal-title":"J Neurosurg Pediatr."},{"key":"10.1016\/j.drudis.2021.12.016_b0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0360-3016(97)00572-5","article-title":"Pediatric brain stem gliomas: a review","volume":"40","author":"Freeman","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"15","key":"10.1016\/j.drudis.2021.12.016_b0085","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1158\/1078-0432.CCR-19-3714","article-title":"Therapeutic efficacy of immune stimulatory thymidine kinase and fms-like tyrosine kinase 3 ligand (TK\/Flt3L) gene therapy in a mouse model of high-grade brainstem glioma","volume":"26","author":"Mendez","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2021.12.016_b0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat Med."},{"issue":"16","key":"10.1016\/j.drudis.2021.12.016_b0095","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2002.04.109","article-title":"Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children\u2019s Cancer Group","volume":"20","author":"Jennings","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/cncr.20741","article-title":"Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children","volume":"103","author":"Broniscer","year":"2005","journal-title":"Cancer."},{"key":"10.1016\/j.drudis.2021.12.016_b0105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/1535-7163.MCT-15-0093","article-title":"ABCG2 and ABCB1 limit the efficacy of dasatinib in a PDGF-B-driven brainstem glioma model","volume":"15","author":"Mittapalli","year":"2016","journal-title":"Mol Cancer Ther."},{"key":"10.1016\/j.drudis.2021.12.016_b0110","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/s41467-019-10043-0","article-title":"The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models","volume":"10","author":"Mart\u00ednez-V\u00e9lez","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.drudis.2021.12.016_b0115","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1021\/acs.nanolett.9b03968","article-title":"Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment","volume":"19","author":"Ruan","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.drudis.2021.12.016_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120888","article-title":"The protein corona hampers the transcytosis of transferrin-modified nanoparticles through blood\u2013brain barrier and attenuates their targeting ability to brain tumor","volume":"274","author":"Xiao","year":"2021","journal-title":"Biomaterials."},{"key":"10.1016\/j.drudis.2021.12.016_b0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/B:NEON.0000024219.47447.91","article-title":"Interstitial infusion of IL13-PE38QQR in the rat brain stem","volume":"67","author":"Souweidane","year":"2004","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11060-014-1589-9","article-title":"Temozolomide after radiotherapy in recurrent \u2018low grade\u2019 diffuse brainstem glioma in adults","volume":"120","author":"Reyes-Botero","year":"2014","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0135","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/neuonc\/not298","article-title":"The potential of theragnostic I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma","volume":"16","author":"Luther","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1020626419269","article-title":"New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery","volume":"60","author":"Carson","year":"2002","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0145","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.stemcr.2016.07.024","article-title":"Intranasal oncolytic virotherapy with CXCR4-enhanced stem cells extends survival in mouse model of glioma","volume":"7","author":"Dey","year":"2016","journal-title":"Stem Cell Reports."},{"key":"10.1016\/j.drudis.2021.12.016_b0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2018.05.005","article-title":"Brainstem blood brain barrier disruption using focused ultrasound: a demonstration of feasibility and enhanced doxorubicin delivery","volume":"281","author":"Alli","year":"2018","journal-title":"J Control Release."},{"key":"10.1016\/j.drudis.2021.12.016_b0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11060-020-03600-x","article-title":"Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma","volume":"149","author":"Elleaume","year":"2020","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0160","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1158\/2159-8290.CD-12-0426","article-title":"Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN","volume":"3","author":"Bjerke","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drudis.2021.12.016_b0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell."},{"issue":"6A","key":"10.1016\/j.drudis.2021.12.016_b0170","first-page":"E11","article-title":"A novel brainstem tumor model: guide screw technology with functional, radiological, and histopathological characterization","volume":"18","author":"Lee","year":"2005","journal-title":"Neurosurg Focus."},{"key":"10.1016\/j.drudis.2021.12.016_b0175","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/jvet.2000.17851","article-title":"Ventral surgical approach to the caudal brain stem in dogs","volume":"29","author":"Klopp","year":"2000","journal-title":"Vet Surg."},{"key":"10.1016\/j.drudis.2021.12.016_b0180","first-page":"355","article-title":"Model for concomitant microdialysis sampling of the pons and cerebral cortex in rhesus macaques (Macaca mulatta)","volume":"63","author":"McCully","year":"2013","journal-title":"Comp Med."},{"key":"10.1016\/j.drudis.2021.12.016_b0185","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: Relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.drudis.2021.12.016_b0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fonc.2015.00172","article-title":"Pre-clinical models of diffuse intrinsic pontine glioma","volume":"5","author":"Misuraca","year":"2015","journal-title":"Front Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","article-title":"Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"106","author":"Chassot","year":"2012","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neo.2015.12.002","article-title":"A novel mouse model of diffuse intrinsic pontine glioma initiated in Pax3-expressing cells","volume":"18","author":"Misuraca","year":"2016","journal-title":"Neoplasia."},{"key":"10.1016\/j.drudis.2021.12.016_b0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2015.10.013","article-title":"A critical evaluation of drug delivery from ligand modified nanoparticles: confounding small molecule distribution and efficacy in the central nervous system","volume":"220","author":"Cook","year":"2015","journal-title":"J Control Release."},{"key":"10.1016\/j.drudis.2021.12.016_b0210","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3171\/jns.2004.101.5.0826","article-title":"Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma","volume":"101","author":"Saito","year":"2004","journal-title":"J Neurosurg."},{"key":"10.1016\/j.drudis.2021.12.016_b0215","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.drudis.2021.12.016_b0220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3171\/2010.3.PEDS09366","article-title":"Establishment of a human glioblastoma stemlike brainstem rodent tumor model","volume":"6","author":"Siu","year":"2010","journal-title":"J Neurosurg Pediatr."},{"key":"10.1016\/j.drudis.2021.12.016_b0225","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1158\/1078-0432.CCR-08-3076","article-title":"Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.drudis.2021.12.016_b0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejca.2011.04.033","article-title":"Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas","volume":"48","author":"Choi","year":"2012","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.drudis.2021.12.016_b0235","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00381-004-1100-6","article-title":"Experimental models of brainstem tumors: development of a neonatal rat model","volume":"21","author":"Jallo","year":"2005","journal-title":"Childs Nerv Syst."},{"key":"10.1016\/j.drudis.2021.12.016_b0240","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3171\/jns.2003.99.5.0893","article-title":"Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats","volume":"99","author":"Degen","year":"2003","journal-title":"J Neurosurg."},{"key":"10.1016\/j.drudis.2021.12.016_b0245","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3171\/JNS\/2008\/109\/11\/0849","article-title":"Brainstem glioma progression in juvenile and adult rats","volume":"109","author":"Liu","year":"2008","journal-title":"J Neurosurg."},{"key":"10.1016\/j.drudis.2021.12.016_b0250","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/neuonc\/noaa058","article-title":"Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma","volume":"22","author":"Bailey","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0255","doi-asserted-by":"crossref","first-page":"vi87","DOI":"10.1093\/neuonc\/now212.363","article-title":"IMST-07. Local regulated IL-12 expression as an immunotherapy for the treatment of pontine glioma","volume":"18","author":"John","year":"2016","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11060-009-9875-7","article-title":"Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas","volume":"94","author":"Barth","year":"2009","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1179\/016164106X115080","article-title":"Establishment of experimental glioma models at the intrinsic brainstem region of the rats","volume":"29","author":"Sho","year":"2007","journal-title":"Neurol Res."},{"key":"10.1016\/j.drudis.2021.12.016_b0270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1354\/vp.39-3-293","article-title":"Experimental rodent models of brainstem tumors","volume":"39","author":"Wu","year":"2002","journal-title":"Vet Pathol."},{"key":"10.1016\/j.drudis.2021.12.016_b0275","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11060-013-1312-2","article-title":"Molecular analysis of diffuse intrinsic brainstem gliomas in adults","volume":"116","author":"Reyes-Botero","year":"2014","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0280","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00381-008-0767-5","article-title":"Neurological grading, survival, MR imaging, and histological evaluation in the rat brainstem glioma model","volume":"25","author":"Thomale","year":"2009","journal-title":"Childs Nerv Syst."},{"key":"10.1016\/j.drudis.2021.12.016_b0285","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/74710","article-title":"Gene therapy of experimental brain tumors using neural progenitor cells","volume":"6","author":"Benedetti","year":"2000","journal-title":"Nat Med."},{"key":"10.1016\/j.drudis.2021.12.016_b0290","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00401-014-1272-4","article-title":"Human pontine glioma cells can induce murine tumors","volume":"127","author":"Caretti","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2021.12.016_b0295","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1253799","article-title":"Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation","volume":"346","author":"Funato","year":"2014","journal-title":"Science (80-)"},{"key":"10.1016\/j.drudis.2021.12.016_b0300","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/cancers13061278","article-title":"Doxorubicin-loaded gold nanoarchitectures as a therapeutic strategy against diffuse intrinsic pontine glioma","volume":"13","author":"Ung","year":"2021","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.drudis.2021.12.016_b0305","doi-asserted-by":"crossref","unstructured":"Izquierdo E, Carvalho DM, Mackay A, Temelso S, Boult JK, Pericoli G, et al. DIPG harbour alterations targetable by MEK inhibitors, with acquired resistance mechanisms overcome by combinatorial inhibition. Cancer Discov. Published online November 4, 2021. http:\/\/dx.doi.org\/10.1158\/2159-8290.CD-20-0930","DOI":"10.1158\/2159-8290.CD-20-0930"},{"key":"10.1016\/j.drudis.2021.12.016_b0310","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00381-017-3344-y","article-title":"Glioblastoma spheroids produce infiltrative gliomas in the rat brainstem","volume":"33","author":"Zhou","year":"2017","journal-title":"Child\u2019s Nerv Syst"},{"key":"10.1016\/j.drudis.2021.12.016_b0315","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11060-009-9954-9","article-title":"A human brainstem glioma xenograft model enabled for bioluminescence imaging","volume":"96","author":"Hashizume","year":"2010","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0320","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1227\/01.NEU.0000350227.61132.A7","article-title":"Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells","volume":"65","author":"Yang","year":"2009","journal-title":"Neurosurgery."},{"key":"10.1016\/j.drudis.2021.12.016_b0325","doi-asserted-by":"crossref","first-page":"E680","DOI":"10.1093\/neuros\/nyaa301","article-title":"Convection-enhanced delivery of enhancer of zeste homolog-2 (EZH2) inhibitor for the treatment of diffuse intrinsic pontine glioma","volume":"87","author":"Sasaki","year":"2020","journal-title":"Neurosurgery."},{"key":"10.1016\/j.drudis.2021.12.016_b0330","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1535-7163.MCT-12-0735","article-title":"WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas","volume":"12","author":"Caretti","year":"2013","journal-title":"Mol Cancer Ther."},{"key":"10.1016\/j.drudis.2021.12.016_b0335","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic pontine glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drudis.2021.12.016_b0340","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-019-01975-4","article-title":"H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo","volume":"137","author":"Silveira","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"17","key":"10.1016\/j.drudis.2021.12.016_b0345","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1039\/C9DT04862F","article-title":"Oxaliplatin and Pt(R, R-DACH)(panobinostat(-2H)) show nanomolar cytotoxicity towards diffuse intrinsic pontine glioma (DIPG)","volume":"49","author":"Boulet","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.drudis.2021.12.016_b0350","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneumeth.2014.09.020","article-title":"Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study","volume":"238","author":"Sewing","year":"2014","journal-title":"J Neurosci Methods."},{"key":"10.1016\/j.drudis.2021.12.016_b0355","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1158\/1078-0432.CCR-20-1499","article-title":"Mesenchymal stem cells successfully deliver oncolytic virotherapy to diffuse intrinsic pontine glioma","volume":"27","author":"Chastkofsky","year":"2021","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.drudis.2021.12.016_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108994","article-title":"Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG","volume":"35","author":"Ehteda","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.drudis.2021.12.016_b0365","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s40478-021-01270-y","article-title":"TP53 wild-type\/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist","volume":"9","author":"Xu","year":"2021","journal-title":"Acta Neuropathol Commun."},{"key":"10.1016\/j.drudis.2021.12.016_b0370","doi-asserted-by":"crossref","unstructured":"Carvalho DM, Richardson PJ, Olaciregui N, Stankunaite R, Lavarino C, Molinari V, et al. Repurposing vandetanib plus everolimus for the treatment of ACVR1-mutant diffuse intrinsic pontine glioma. Cancer Discov. Published online September 22, 2021. http:\/\/dx.doi.org\/10.1158\/2159-8290.CD-20-1201.","DOI":"10.1158\/2159-8290.CD-20-1201"},{"key":"10.1016\/j.drudis.2021.12.016_b0375","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41467-021-20896-z","article-title":"Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas","volume":"12","author":"Khan","year":"2021","journal-title":"Nat Commun."},{"key":"10.1016\/j.drudis.2021.12.016_b0380","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/neuonc\/nor190","article-title":"Genomic aberrations in pediatric diffuse intrinsic pontine gliomas","volume":"14","author":"Warren","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0385","doi-asserted-by":"crossref","first-page":"52543","DOI":"10.18632\/oncotarget.15002","article-title":"New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis","volume":"8","author":"Plessier","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.drudis.2021.12.016_b0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PLoS ONE."},{"key":"10.1016\/j.drudis.2021.12.016_b0395","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2021.12.016_b0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ccell.2020.02.002","article-title":"Mutant ACVR1 arrests glial cell differentiation to drive tumorigenesis in pediatric gliomas","volume":"37","author":"Fortin","year":"2020","journal-title":"Cancer Cell."},{"issue":"44","key":"10.1016\/j.drudis.2021.12.016_b0405","doi-asserted-by":"crossref","first-page":"76644","DOI":"10.18632\/oncotarget.19656","article-title":"Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.drudis.2021.12.016_b0410","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1570159X14666160523144117","article-title":"Patient-derived tumor models for diffuse intrinsic pontine gliomas","volume":"15","author":"Hashizume","year":"2017","journal-title":"Curr Neuropharmacol."},{"issue":"18","key":"10.1016\/j.drudis.2021.12.016_b0415","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/1078-0432.CCR-18-3890","article-title":"Radiosensitization by histone H3 demethylase inhibition in diffuse intrinsic pontine glioma","volume":"25","author":"Katagi","year":"2019","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.drudis.2021.12.016_b0420","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/neuonc\/noaa249","article-title":"Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-na\u00efve diffuse midline glioma models","volume":"23","author":"Vitanza","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0425","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41591-018-0086-7","article-title":"Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells","volume":"24","author":"Vinci","year":"2018","journal-title":"Nat Med."},{"key":"10.1016\/j.drudis.2021.12.016_b0430","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat Med."},{"key":"10.1016\/j.drudis.2021.12.016_b0435","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5414\/NP301331","article-title":"Diffuse midline glioma H3 K27M-mutant in adults: a report of six cases and literature review","volume":"40","author":"Alzoubi","year":"2021","journal-title":"Clin Neuropathol."},{"key":"10.1016\/j.drudis.2021.12.016_b0440","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36696","article-title":"H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers","volume":"7","author":"Fang","year":"2018","journal-title":"Elife."},{"key":"10.1016\/j.drudis.2021.12.016_b0445","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20171046","article-title":"Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy","volume":"215","author":"Chheda","year":"2018","journal-title":"J Exp Med."},{"key":"10.1016\/j.drudis.2021.12.016_b0450","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet."},{"key":"10.1016\/j.drudis.2021.12.016_b0455","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1038\/s41467-019-11732-6","article-title":"PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma","volume":"10","author":"Fons","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.drudis.2021.12.016_b0460","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nprot.2012.060","article-title":"Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS\/TVA system","volume":"7","author":"Von Werder","year":"2012","journal-title":"Nat Protoc."},{"key":"10.1016\/j.drudis.2021.12.016_b0465","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/0008-5472.CAN-09-2503","article-title":"Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma","volume":"70","author":"Becher","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2021.12.016_b0470","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG","volume":"15","author":"Cordero","year":"2017","journal-title":"Mol Cancer Res."},{"key":"10.1016\/j.drudis.2021.12.016_b0475","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41467-019-08823-9","article-title":"ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis","volume":"10","author":"Hoeman","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.drudis.2021.12.016_b0480","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/neuros\/nyz212","article-title":"ABC transporter inhibition plus dexamethasone enhances the efficacy of convection enhanced delivery in H3.3K27M mutant diffuse intrinsic pontine glioma","volume":"86","author":"Tsvankin","year":"2020","journal-title":"Neurosurgery."},{"key":"10.1016\/j.drudis.2021.12.016_b0485","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00280-021-04313-2","article-title":"Panobinostat penetrates the blood-brain barrier and achieves effective brain concentrations in a murine model","volume":"88","author":"Homan","year":"2021","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.drudis.2021.12.016_b0490","first-page":"381","article-title":"Generation of diffuse intrinsic pontine glioma mouse models by brainstem-targeted in utero electroporation","volume":"22","author":"Patel","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0495","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1101\/gad.1839510","article-title":"Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure","volume":"24","author":"Phoenix","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.drudis.2021.12.016_b0500","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc.2016.91","article-title":"Mouse models in oncoimmunology","volume":"16","author":"Zitvogel","year":"2016","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.drudis.2021.12.016_b0505","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","article-title":"Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment","volume":"110","author":"Hashizume","year":"2012","journal-title":"J Neurooncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0510","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/cells8080889","article-title":"Application of highly immunocompromised mice for the establishment of patient-derived xenograft (PDX) models","volume":"8","author":"Okada","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.drudis.2021.12.016_b0515","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","article-title":"Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice","volume":"154","author":"Shultz","year":"1995","journal-title":"J Immunol."},{"key":"10.1016\/j.drudis.2021.12.016_b0520","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","article-title":"NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells","volume":"100","author":"Ito","year":"2002","journal-title":"Blood."},{"key":"10.1016\/j.drudis.2021.12.016_b0525","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000416","article-title":"Characterization of human cancer xenografts in humanized mice","volume":"8","author":"Rios-Doria","year":"2020","journal-title":"J Immunother Cancer."},{"issue":"5570","key":"10.1016\/j.drudis.2021.12.016_b0530","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.296.5570.1005b","article-title":"Genome sequencing. Public group completes draft of the mouse","volume":"296","author":"Marshall","year":"2002","journal-title":"Science."},{"key":"10.1016\/j.drudis.2021.12.016_b0535","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acschemneuro.8b00607","article-title":"Real-time, in vivo correlation of molecular structure with drug distribution in the brain striatum following convection enhanced delivery","volume":"10","author":"Tosi","year":"2019","journal-title":"ACS Chem Neurosci."},{"key":"10.1016\/j.drudis.2021.12.016_b0540","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ccell.2019.09.005","article-title":"Re-programing chromatin with a bifunctional LSD1\/HDAC inhibitor induces therapeutic differentiation in DIPG","volume":"36","author":"Anastas","year":"2019","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drudis.2021.12.016_b0545","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ccell.2020.07.008","article-title":"Integrated metabolic and epigenomic reprograming by H3K27M mutations in diffuse intrinsic pontine gliomas","volume":"38","author":"Chung","year":"2020","journal-title":"Cancer Cell."},{"key":"10.1016\/j.drudis.2021.12.016_b0550","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/neuonc\/noz053","article-title":"Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma","volume":"21","author":"Akamandisa","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drudis.2021.12.016_b0555","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0715-827a","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med."},{"key":"10.1016\/j.drudis.2021.12.016_b0560","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canlet.2017.04.019","article-title":"The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma","volume":"400","author":"Miyahara","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drudis.2021.12.016_b0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077639","article-title":"PD\u20130332991, a CDK4\/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma","volume":"8","author":"Barton","year":"2013","journal-title":"PLoS ONE."},{"key":"10.1016\/j.drudis.2021.12.016_b0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118926","article-title":"A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent","volume":"10","author":"Halvorson","year":"2015","journal-title":"PLoS ONE."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621005675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644621005675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:59:10Z","timestamp":1761224350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644621005675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1359644621005675"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2021.12.016","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental murine models of brainstem gliomas","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2021.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}